Hallucinations and dementia; prevalence, clinical presentation and pathophysiology;Hallucinations et démences; prévalence, sémiologie et pathophysiologie

Revue Neurologique

Volumn 160, Issue 4 II, 2004, Pages

  Fenelon G ^a   Mahieux, F ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL CHARLES FOIX   (France)

Author keywords

Alzheimer's disease; Dementia; Dementia with Lewy bodies; Hallucinations; Parkinson's disease

Indexed keywords

ALZHEIMER DISEASE; AUDITORY HALLUCINATION; CLINICAL FEATURE; CONFERENCE PAPER; DELUSION; DEMENTIA; DEPRESSION; EYE DISEASE; HALLUCINATION; HUMAN; ILLUSION; LEWY BODY; MONOAMINERGIC SYSTEM; NEUROIMAGING; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; VISUAL HALLUCINATION; BIOLOGICAL MODEL; COGNITIVE DEFECT; REVIEW;

COGNITION DISORDERS; DEMENTIA; HALLUCINATIONS; HUMANS; MODELS, NEUROLOGICAL; PREVALENCE;

EID: 2342535761     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (122)

1. AARSLAND D, BALLARD C, LARSEN JP MCKEITH I. (2001). A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry, 16: 528-36.
2. AARSLAND D, LARSEN JP, LIM NG et al. (1999). Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry, 67: 492-6.
3. ABE Y, KACHI T, KATO T et al. (2003). Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry, 74: 419-22.
4. AGID Y, RUBERG M, RAISMAN R, HIRSCH E, JAVOY-AGID F. (1990). The biochemistry of Parkinson's disease. In: STERN G. Parkinson's disease. London, Chapman and Hall, pp. 99-125.
5. ALA TA, YANG KH, SUNG JH, FREY II WH. (1997). Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinico-pathological study. J Neurol Neurosurg Psychiatry, 62: 16-21.
6. ALBIN RL, MINOSHIMA S, D'AMATO CJ, FREY KA, KUHL DA, Sima AAF. (1996). Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology, 47: 462-6.
7. ARNULF I, BONNET AM, DAMIER P et al. (2000). Hallucinations, REM sleep, and Parkinson's disease. A medical hypothesis. Neurology, 55: 281-8.
8. BAILBÉ M, KAROLEWICZ S, NEAU JP, DUMAS P, GIL R. ET L'ASSOCIATION DES NEUROLOGUES DU POITOU-CHARENTES. (2002). Hallucinations, idées délirantes, évènements nocturnes chez 152 patients atteints de maladie de Parkinson. Enquête régionale. Rev Neurol, 158: 203-10.
9. BALLARD C, BANNISTER C, GRAHAM C, OYEBODE F, WILCOCK G. (1995). Associations of psychotic symptoms in dementia sufferers. Br J Psychiatry, 167: 537-40.
10. BALLARD C, GRAY A, AYRE G. (1999a). Psychotic symptoms, aggression and restlessness in dementia. Rev Neural, 155: 44-52.
11. BALLARD C, HOLMES C, MCKEITH I et al. (1999b). Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry, 156: 1039-45.
12. BALLARD C, MCKEITH I, HARRISON R et al. (1997). A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease. Int Psychogeriatr, 9: 381-8.
13. BARBER R, PANIKKAR A, MCKEITH IG. (2001). Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 16, S12-S18.
14. BARNES J, BOUBERT L, HARRIS J, LEE A, DAVID AS. (2003). Reality monitoring and visual hallucinations in Parkinson's disease. Neuropsychologia, 41: 565-74.
15. BARNES J, DAVID AS. (2001). Visual hallucinations in Parkinson's disease.: a review and phenomenological survey. J Neurol Neurosurg Psychiatry, 70: 727-33.
16. BASSIONY MM, STEINBERG MS, WARREN A, ROSENBLATT A, BAKER AS, LYKETSOS CG. (2000). Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates. Int J Geriat Psychiatry, 15: 99-107.
17. BASSIONY MM, WARREN A, ROSENBLATT A et al. (2002). The relationship between delusions and depression in Alzheimer's disease. Int J Geriatr Psychiatry, 17: 549-56.
18. BOZEAT S, GREGORY CA, LAMSON RALPH MA, HODGES JR. (2000). Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 69: 178-86.
19. BURKE W. (2002). The neural basis of Charles Bonnet hallucinations: a hypothesis. J Neurol Neurosurg Psychiatry, 73: 535-41.
20. BURNS A, JACOBY R, LEVY R. (1990). Psychiatric phenomena in Alzheimer's disease. Br J Psychiatry, 157: 72-96.
21. CAMBIER J. (2002). L'hallucination, une impasse dans la synthèse de l'objet. In Fénelon G, Cambler J et Widlöcher D (eds), Hallucinations. Regards croisés. Masson, Acanthe, Paris, 2002, pp: 279-89.
22. CHAN D, ROSSOR MN. (2002). "-but who is that on the other side of you?" Extracampine hallucinations revisited. Lancet, 360: 2064-6.
23. CHAPMAN FM, DICKINSON J, MCKEITH I, BALLARD C. (1999). Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. Am J Psychiatry, 156: 1983-5.
24. CHUI HC, LYNESS SA, SOBEL E, SCHNEIDER LS. (1994). Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol, 51: 676-81.
25. CLAUDE H, EY H. (1933). Troubles psycho-sensoriels et états oniriques dans l'encéphalite épidémique chronique. Presse Med, 104: 1281-5.
26. COLLOBY SJ, FENWICK JD, WILLIAMS ED et al. (2002). A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging, 29: 615-22.
27. CUMMINGS JL, MEGA M, GRAY K, ROSENBERG-THOMPSON S, CARUSI PA, GORNBEIN J. (1994). The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44: 2308-14.
28. DE LA FUENTE-FERNANDEZ R, NUNEZ MA, LOPEZ OL. (1999). Apolipoprotein E ε4 increases the risk of drug-induced hallucinations in Parkinson's disease. Clin Neuropharmacol, 22: 226-30.
29. DE MORSIER G. (1967). Le syndrome de Charles Bonnet: hallucinations visuelles des vieillards sans déficience mentale. Ann Méd Psychol, 125: 677-702.
30. DEVANAND DP, JACOBS DM, TANG MX et al. (1997). The course of psychopathologic features in mild to moderate Alzheimer's disease. Arch Gen Psychiatry, 54: 257-63.
31. DEVANAND DP, MILLER L, RICHARDS M et al. (1992). The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol, 49: 371-6.
32. DIEDERICH NJ, GOETZ CG, RAMAN R, PAPPERT EJ, LEURGANS S, PIERY V. (1998). Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol, 21: 289-95.
33. DIERKS T, LINDEN DEJ, JANDL M et al. (1999). Activation of Heschl's gyrus during auditory hallucinations. Neuron, 22: 615-21.
34. DoÉ A, FÉNELON G, MAHIEUX F. (2000). Hallucinations in Parkinson's disease: a follow-up study. Mov Disord, 15: 189 [abst].
35. DONNEMILLER E, HEILMAN J, WENNING GK et al. (1997). Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 1231-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med, 24: 320-5.
36. DRAPER D, POLARD E, BENTUE-FERRER D, ALLAIN H. (2002). Substances et hallucinations. In: Michel BF, Arnaud-Castiglioni R, Derouesné C, Clément J-P. Hallucinations et maladies neurodégéné ratives, Marseille, Solal, pp. 173-188.
37. DREVETS WC, RUBIN EH. (1989). Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry, 25: 39-48.
38. FÉNELON G. (2001). Démons et dements: hallucinations et maladies neurodégénératlves. Rev Neuropsychol, 11: 267-82.
39. FÉNELON G. (2003). Le syndrome de Charles Bonnet. Psychol NeuroPsychiatr Vieillissement, 2: 121-127.
40. FÉNELON G, BELLIVIER F. (2003). Hallucinations du troisième âge. Rev Fr Geriatr Gerontol, 10: 186-92.
41. FÉNELON G, MAHIEUX F, HUON R, ZIÉGLER M. (2000). Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain, 123: 733-45.
42. FÉNELON G, THOBOIS S, BONNET AM, BROUSSOLLE E, TISON E (2002). Tactile hallucinations in Parkinson's disease. J Neurol, 249: 1699-703.
43. FFYTCHE DH, HOWARD RJ, BRAMMER MJ, DAVID A, WOODRUFF P, WILLIAMS S. (1998). The anatomy of conscious vision: an fMRI study of visual hallucinations. Nature Neurosci, 1: 738-42.
44. FINKEL SI, COSTA E SILVA J, COHEN GD, MILLER S, SARTORIUS N. (1998). Behavioral and psychological symptoms of dementia. A consensus statement on current knowledge and implications for research and treatement. Am J Geriatr Psychiatry, 6: 97-100.
45. FRANCIS PT, PALMER AM, SNAPE M, WILCOCK GK. (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry, 66: 137-47.
46. FRIEDBERG G, ZOLDAN J, WEIZMAN A, MELAMED E. (1998). Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol, 21: 280-4.
47. FRITH C. (1995). Functional imaging and cognitive abnormalities. Lancet, 346: 615-20.
48. GILADI N, TREVES TA, PALEACU D et al. (2000). Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm, 107: 59-71.
49. GNALINGHAM KK, BYRNE EJ, THORNTON A, SAMBROOK MA, BANNISTER P. (1997). Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry, 62: 243-52.
50. GOETZ CG, LEURGANS S, PAPPERT EJ, RAMAN R, STEMER AB. (2001a). Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology, 57: 2078-82.
51. GOETZ CG, BURKE PF, LEURGANS S, BERRY-KRAVIS E, BLASUCCI LM, RAMAN R. (2001b). Genetic variation analysis in Parkinson's disease in patients with and without hallucinations. Arch Neurol, 58: 209-13.
52. GOETZ CG, PAPPERT EJ, BLASUCCI LM et al. (1998). Intravenous levodopa infusions in hallucinating Parkinson's disease patients: high dose challenge does not precipitate hallucinations. Neurology, 50: 515-7.
53. GRAHAM JM, GRONEWALD RA, SAGAR HJ. (1997). Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry, 63, 434-40.
54. HAAN MN, JAGUST WJ, GALASKO D, KAYE J. (2002). Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer's disease. Arch Neurol, 59: 588-93.
55. HARDING AJ, BROE GA, HALLIDAY GM. (2002a). Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain, 125: 391-403.
56. HARDING AJ, STIMSON E, HENDERSON JM, HALLIDAY GM. (2002b). Clinical correlates of selective pathology in the amygdale of patients with Parkinson's disease. Brain, 125: 2431-45.
57. HOHL U, TIRABOSCHI P, HANSEN LA, THAL LJ, COREY-BLOOM J. (2000). Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol, 57: 347-51.
58. HOLMES C, SMITH H, GANDERTON R et al. (2001). Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J Neurol Neurosurg Psychiatry, 71: 777-9.
59. HOLROYD S, CURRIE L, WOOTEN GF. (2001). Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry, 70: 734-8.
60. HOLROYD S, RABINS PV, FINKELSTEIN D, LAVRISHA M. (1994). Visual hallucinations in patients from an ophthalmologic clinic and medical clinic population. J Nerv Ment Dis, 182: 273-6.
61. HOLROYD S, SHELDON-KELLER A. (1995). A study of visual hallucinations in Alzheimer's disease. Am J Geriatr Psychiatry 3: 198-205.
62. HOPE T, KEENE J, FAIRBURN CG, JACOBY R, MCSHANE R. (1999). Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study. Br J Psychiatry, 174: 39-44.
63. HOWARD RJ, WILLIAMS SCR, BULLMORE E et al. (1995). Cortical response to exogenous visual stimulation during visual hallucinations. Lancet, 345: 70.
64. HWANG JP, YANG CH, TSAI SJ. (2003). Phantom boarder symptom in dementia. Int J Geriatr Psychiatry, 18: 1-4.
65. IMAMURA T, ISHII K, HIRONO N et al. (1999). Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport, 10: 1903-7.
66. INTERNATIONAL PSYCHOGERIATRIC ASSOCIATION. (2002). Behavioral and psychological symptoms of dementia. Educational pack, Module 2: clinical issues. http://www.ipa-online.org
67. INZELBERG R, KIPERVASSER S, KORCZYN AD. (1998). Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry, 64: 533-5.
68. ISHII K, YAMAGI S, KITAGI H, IMAMURA T, HIRONO N, MORI E. (1999). Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology, 53: 413-6.
69. JEANNEROD M. (2003). Les troubles de la reconnaissance de soi: une approche neuropsychologique des symptômes positifs de la schizophrénie. Médecine/Sciences, 19: 621-4.
70. KIVELA SL, PAHKALA K. (1988). Hallucinatory depression in the elderly: a community study. ZFA, 43: 331-9.
71. KLATKA LA, LOUIS ED, SCHIFFER RB. (1996). Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology, 47: 1148-52.
72. KNIGHT RT, GRABOWECKY ME (2000). Prefrontal cortex, time, and consciousness. In: Gazzaniga MS. The new cognitive neurosciences, 2nd edition, Cambridge (Mass), London, MIT Press, pp 1319-1339.
73. KOTRLA KJ, CHACKO RC, HARPER RG. JHINGRAN S, DOODY R. (1995). SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry, 152: 1470-5.
74. LEROI I, VOULGARI A, BREITNER JCS, LYKETSOS CG. (2003). The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry, 11: 83-91.
75. LEVY ML, MILLER BL, CUMMINGS JL, FAIRBANKS LA, CRAIG A. (1996). Alzheimer disease and frontotemporal dementia. Arch Neurol, 53: 687-90.
76. LHERMITTE J. (1932). L'hallucinose pédonculaire. Encéphale, 27: 422-35.
77. LOBOTESIS K, FENWICK JD, PHIPPS A et al. (2001). Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology, 56: 643-9.
78. MAHIEUX F. (1997). Troubles neuropsychologiques au cours de la maladie de Parkinson. Étude de prévalence des troubles cognitifs et suivi longitudinal d'une cohorte. Thèse de Doctorat de l'Université Paris 6.
79. MAKOFF AJ, GRAHAM JM, ARRANZ MJ et al. (2000). Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics, 10: 43-8.
80. MANFORD M, ANDERMANN F. (1998). Complex visual hallucinations. Clinical and neurobiological insights. Brain, 121: 1819-40.
81. MANNI R, PACCHETTI C, TERZAGHI M, SARTORI I, MANCINI F, NAPPI G. (2002). Hallucinations and slee-wake cycle in PD. A 24-hour continuous polysomnographic study. Neurology, 59: 1979-81.
82. MARDER K, ZHAO H, MYERS RH et al. (2000). Rate of functional decline in Huntington disease. Neurology, 54: 452-8.
83. MARTINOT JL, ARTIGES E, BARTRES FAZ, PAILÈRE ML, BERTHOZ S. (2002). Voir les hallucinations: l'image cérébrale des hallucinations. In: Fénelon G, Cambier J, Widlöcher D. Hallucinations. Regards croisés. Paris, Masson, Acanthe, pp. 95-112.
84. MAUGUIÈRE F. (1999). Scope and presumed mechanisms of hallucinations in partial epileptic seizures. Epileptic Disorders, 1: 81-91.
85. MAURAGE CA, DUYCKAERTS C. (2002). Neuropathologie de la démence à corps de Lewy et des démences de la maladie de Parkinson. In: Duyckaerts C, Pasquier F. Démences. Paris, Doin, pp: 203-11.
86. MCKEITH IG. (2002). Dementia with Lewy bodies. Br J Psychiatry, 180: 144-7.
87. MCKEITH I, DEL SER T, SPANO P et al. (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356: 2031-6.
88. MCKEITH IG, GALASKO D, KOSAKA K et al, for the Consortium on Dementia with Lewy Bodies. (1996). Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology, 47: 1113-24.
89. MCSHANE R, GEDLING K, READING M, MCDONALD B, ESIRI MM, HOPE T. (1995). Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 59: 185-8.
90. MCSHANE R, KEENE J, GEDLING K, FAIRBURN C, JACOBY R, HOPE T. (1997). Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. Br Med J 1997;314: 266-70.
91. MEGA MS, LEE L, DINOV ID, MISHKIN F, TOGA AW, CUMMINGS JL. (2000). Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 69: 167-71.
92. MELLET E. (2002). La perception et l'imagerie mentale visuelles. In: Houdé O, Mazoyer B, Tzourio-Mazoyer N. Cerveau et psychologie. Paris, Presses Universitaires de France, pp. 403-35.
93. MOHLO ES. (2002). Psychosis and related problems. In: Factor SA, Weiner WJ. Parkinson's disease. Diagnosis and clinical management. New-York, Demos, pp. 465-80.
94. MORI E, SHIMOMURA T, FUJIMORRI M et al. (2000). Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol, 57: 489-93.
95. MURGATROYD C, PRETTYMAN R. (2001). An investigation of visual hallucinosis and visual sensory status in dementia. Int J Geriatr Psychiatry, 16: 709-13.
96. NACMIAS B, TEDDE A, FORLEO P et al. (2001). Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease. Biol Psychiatry, 50: 472-5.
97. PAPPERT EJ, GOETZ CG, NIEDERMAN FG, RAMAN R, LEURGANS S. (1999). Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord, 14: 117-21.
98. PARANT V. (1883). La paralysie agitante examinée comme cause de folie. Ann Méd Psychol, 10: 45-66.
99. PAULSEN JS, SALMON DP, THAL LJ et al. (2000). Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology, 54: 1965-71.
100. PERRY EK, PERRY RH. (1996). Altered consciousness and transmitter signalling in Lewy body dementia. In: Perry R, McKeith I, Perry E. Dementia with Lewy bodies. Clinical, pathological, and treatment issues. Cambridge, Cambridge University Press, pp. 397-413.
101. REISBERG B, BORENSTEIN J, SALO SP, FERRIS SH, FRANSSEN E, GEORGOTAS A. (1987). Behavioral syptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry, 48: 9-15.
102. RUBIN EH, DREVETS WC, BURKE WJ. (1988). The nature of psychotic symptoms in senile dementia of the Alzheimer's type. J Geriatr Psychiatry Neurol, 1: 16-20.
103. SALADINI O, LUAUTÉ JP, MULLER P, FORRAY JP, SCHNEIDER P, GÉLIN V. (2000). Troubles auditifs et psychose hallucinatoire chronique: fortuitôme ou relation ? Ann Méd Psychol, 158: 589-94.
104. SALMON E. (2002). Functional brain imaging applications to differential diagnosis in the dementias. Curr Opin Neurol, 15: 439-44.
105. SANCHEZ-RAMOS JR, ORTOLL R, PAULSON GW. (1996). Visual hallucinations associated with Parkinson's disease. Arch Neurol, 53: 1265-8.
106. SHERGILL SS, BRAMMER MJ, WILLIAMS SCR, MURRAY RM, MCGUIRE PK. (2000). Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry, 57: 1033-8.
107. SHERGILL SS, CAMERON LA, BRAMMER MJ, WILLIAMS SCR, MURRAY RM, MCGUIRE PK. (2001). Modality specific neural correlates of auditory and somatic hallucinations. J Neurol Neurosurg Psychiatry, 71: 688-90.
108. SHIMOMURA T, MORI E, YAMASHITA H et al. (1998). Cognitive loss in dementia with Lewy bodies and Alzheimer's disease. Arch Neurol, 55: 1552.
109. STERN Y, LIU X, ALBERT M, et al. (1996). Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Arch Neurol, 53: 1121-6.
110. SWEET RA, NIMGAONKAR VL, KAMBOH MI, LOPEZ OL, ZHANG F, DEKOSKY ST. (1998). Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer's disease. Arch Neurol, 55: 1335-40.
111. TARIOT PN, MACK JL, PATTERSON MB et al. (1995). The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry, 152: 1349-57.
112. TEUNISSE RJ, CRUYSBERG JRM, VERBEEK A, ZIITMAN FG. (1995). The Charles Bonnet syndrome: a large prospective study in the Netherlands. Br J Psychiatry, 166: 254-7.
113. TIEN AY. (1991). Distributions of hallucinations in the population. Soc Psychiatry Epidemiol, 26: 287-92.
114. TIRABOSCHI P, HANSEN LA, ALFORD M et al. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry, 59: 946-51.
115. TSUANG DW, DALAN AM, EUGENIO CJ et al. (2002). Familial dementia with Lewy bodies. A clinical and neuropathological study. Arch Neurol, 59: 1622-30.
116. TURNER TH, COOKSON JC, WASS JA, DRURY PL, PRICE PA, BESSER GM. (1984). Psychotic reactions during treatment of pituitary tumours with dopamine agonists. Br Med J, 289: 1101-3.
117. TURVEY CL, SCHULTZ SK, ARNDT S, ELLINGROD V, WALLACE R, HERZOG R. (2001). Caregiver report of hallucinations and paranoid delusions in elders aged 70 or older. Int Psychogeriatr, 13: 241-9.
118. VANDER BORGHT, MINOSHIMA S, GIORDANI B et al. (1997). Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J Nucl Med, 38: 797-802.
119. VAPHIADES ES, CELESIA GG, BRIGELL MG. (1996). Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology, 47: 408-17.
120. WEBSTER J, GROSSBERG GT. (1998). Late-life onset of psychotic symptoms. Am J Geriatr Psychiatry, 6: 196-202.
121. WEISS AP, HECKERS S. (1999). Neuroimaging of hallucinations: a review of the literature. Psychiatry Research, 92: 61-74.
122. WILSON RS, GILLEY DW, BENNET DA, BECKETT LA, EVANS DA. (2000). Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 69: 172-7.